Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04443010
What this trial is testing

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Philogen S.p.A. 226
Testing effectiveness (Phase 2)Study completedNCT00042991
What this trial is testing

Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas

Who this might be right for
Untreated Childhood Anaplastic AstrocytomaUntreated Childhood Anaplastic OligodendrogliomaUntreated Childhood Brain Stem Glioma+5 more
National Cancer Institute (NCI) 69
Early research (Phase 1)WithdrawnNCT00703859
What this trial is testing

Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
AHS Cancer Control Alberta
Early research (Phase 1)Study completedNCT00045565
What this trial is testing

Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03919071
What this trial is testing

Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic Astrocytoma, Not Otherwise SpecifiedAnaplastic Ganglioglioma+5 more
National Cancer Institute (NCI) 58
Large-scale testing (Phase 3)Study completedNCT03345095
What this trial is testing

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Newly Diagnosed Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 749
Testing effectiveness (Phase 2)Study completedNCT00974987
What this trial is testing

Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 32
Early research (Phase 1)WithdrawnNCT00904852
What this trial is testing

Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Millennium Pharmaceuticals, Inc. 30
Very early researchLooking for participantsNCT06831526
What this trial is testing

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04485949
What this trial is testing

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Who this might be right for
Glioblastoma
Imvax 99
Early research (Phase 1)Ended earlyNCT02722512
What this trial is testing

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IIIAnaplastic Ependymoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Testing effectiveness (Phase 2)Ended earlyNCT00052715
What this trial is testing

Biological Therapy and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 31
Early research (Phase 1)Study completedNCT03867123
What this trial is testing

Evaluate the Safety of LAM561 Added to Standard of Care in Newly-diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma (GBM)
Laminar Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT00731731
What this trial is testing

Vorinostat, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 125
Early research (Phase 1)Study completedNCT00639639
What this trial is testing

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Malignant Neoplasms of Brain
Gary Archer Ph.D. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05084430
What this trial is testing

Study of Pembrolizumab and M032 (NSC 733972)

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaGliosarcoma
University of Alabama at Birmingham 28
Testing effectiveness (Phase 2)Looking for participantsNCT05768919
What this trial is testing

Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas

Who this might be right for
Glioblastoma
SignPath Pharma, Inc. 30
Early research (Phase 1)Looking for participantsNCT07089641
What this trial is testing

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Who this might be right for
GlioblastomaGlioblastoma, IDH-WildtypeGliosarcoma+3 more
Jonsson Comprehensive Cancer Center 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT05100641
What this trial is testing

AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM

Who this might be right for
Primary Glioblastoma
Aivita Biomedical, Inc. 672
Testing effectiveness (Phase 2)Active Not RecruitingNCT02455557
What this trial is testing

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Roswell Park Cancer Institute 66
Next Page